1![Gene Transfer Safety Assessment Board Adverse Event Report NIH Office of Biotechnology Activities December 2013 Protocol Number: Protocol Title: Gene Transfer Safety Assessment Board Adverse Event Report NIH Office of Biotechnology Activities December 2013 Protocol Number: Protocol Title:](https://www.pdfsearch.io/img/ee0af985b02a3ba51944231fd1c7e2e1.jpg) | Add to Reading ListSource URL: osp.od.nih.govLanguage: English - Date: 2014-07-21 14:55:58
|
---|
2![1 Session IV: Scientific and Commercial Challenges Review of Selected 1 Session IV: Scientific and Commercial Challenges Review of Selected](https://www.pdfsearch.io/img/f1bcf5e1af5b2491942809a7b40f9ccd.jpg) | Add to Reading ListSource URL: osp.od.nih.govLanguage: English - Date: 2014-01-13 09:48:03
|
---|
3![1 Session IV: Scientific and Commercial Challenges Review of Selected 1 Session IV: Scientific and Commercial Challenges Review of Selected](https://www.pdfsearch.io/img/2e6a8d2195f94fcdec79d08e98a870dc.jpg) | Add to Reading ListSource URL: osp.od.nih.govLanguage: English - Date: 2014-01-09 16:17:57
|
---|
4![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA. • HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA. •](https://www.pdfsearch.io/img/95985d426ac3ef1e82e885f4d08ce2f1.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-04-17 12:59:23
|
---|
5![Arzerra II-27 Final DHPC and communication plan Arzerra II-27 Final DHPC and communication plan](https://www.pdfsearch.io/img/7639eb40f5875b0b43d539c94661b388.jpg) | Add to Reading ListSource URL: www.mhra.gov.ukLanguage: English - Date: 2014-07-31 09:55:30
|
---|
6![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA. • HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA. •](https://www.pdfsearch.io/img/c5a36853ac203d7781ce059cd90ac72a.jpg) | Add to Reading ListSource URL: www.gsksource.comLanguage: English - Date: 2014-08-21 00:16:10
|
---|
7![ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS](https://www.pdfsearch.io/img/43e6151acad034c810ea3180b4b02c72.jpg) | Add to Reading ListSource URL: www.ema.europa.euLanguage: English - Date: 2014-02-27 10:08:11
|
---|